跳至主要内容
临床试验/IRCT20200404046937N3
IRCT20200404046937N3已完成3 期

The study of the effect of herbal drug Phyllanthus Emblica, Rosa Damascene, Althaea Officinalis and Honey in patient with covid 19 referring to Ahvaz Jundishapur university of Medical Science hospitals.

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age =18 years
  • Laboratory polymerase chain reaction (PCR) confirmed infection with COVID19
  • Lung involvement confirmed with chest imaging
  • Hospitalized with: Fever or Respiratory rate >24/min Or Cough
  • Less than 8 days since illness onset
  • Willingness of study participant to accept randomization to any assigned treatment arm
  • Acceptance of non-participation in another study before the 28th day of the study

排除标准

  • Receipt of any experimental treatment for COVID 19 within the 30 days prior to the time of the screening evaluation
  • Severe liver disease
  • Known allergic reaction to drugs
  • Severe renal disease
  • Pregnant or breastfeeding women
  • Transfer to another hospital within the next 72 hours

研究者

相似试验